News
JYNT
13.06
+2.27%
0.29
Weekly Report: what happened at JYNT last week (0318-0322)?
Weekly Report · 3d ago
Wednesday Sector Laggards: Rental, Leasing, & Royalty, Cigarettes & Tobacco Stocks
NASDAQ · 03/20 16:32
Weekly Report: what happened at JYNT last week (0311-0315)?
Weekly Report · 03/18 10:31
The Joint Corp. (JYNT) Moves 10.1% Higher: Will This Strength Last?
NASDAQ · 03/12 14:44
The Joint (JYNT) Rises 30% as Q4 Earnings Beat on Higher Clinics
NASDAQ · 03/11 15:09
Weekly Report: what happened at JYNT last week (0304-0308)?
Weekly Report · 03/11 10:29
Maintaining Hold: Balancing The Joint Corp’s Strong Financials with Strategic Uncertainties
TipRanks · 03/09 12:37
Joint Corp Is Worried About This – Should You Be Worried Too?
TipRanks · 03/09 06:01
Dow Gains Over 100 Points; AerSale Shares Plunge After Q4 Results
U.S. Stocks traded mixed toward the end of trading on Friday. The Dow traded up 0.27% to 38,894.21 while the NASDAQ fell 0.51%. Real estate shares jumped by 0.9% on Friday while information technology shares fell by 1.8%. Nonfarm payrolls beat economist estimates and average hourly wages grew at a 0.1% monthly pace in February. Asian markets closed higher on Friday and European shares were mixed.
Benzinga · 03/08 19:51
Why Marvell Technology Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of Marvell Technology, Inc. Fell 9.6% to $76.91 on Friday. The company reported fourth-quarter financial results and issued weak Q1 guidance. Ainos, Inc., jumped 140% after dipping 18% on Thursday. Other stocks moving in the mid-day session included Aino's, Psyence Biomedical and Willdan Group.
Benzinga · 03/08 18:47
12 Health Care Stocks Moving In Friday's Intraday Session
Psyence Biomedical stock moved upwards by 137.8% to $3.02 during Friday's regular session. Ainos (NASDAQ:AIMD) stock rose by 91.96% during the session. Mira Pharmaceuticals, Grifols and Lantern Pharma were among the winners.
Benzinga · 03/08 17:31
Friday Sector Leaders: Rental, Leasing, & Royalty, Real Estate Stocks
NASDAQ · 03/08 16:59
Analysts Offer Insights on Healthcare Companies: Joint (JYNT), IGM Biosciences (IGMS) and Optinose (OPTN)
3 analysts have maintained Buy ratings on 3 stocks in the Healthcare sector. Joint, IGM Biosciences and Optinose are among the 3 stocks with bullish sentiments. Joint has an analyst consensus of a Buy rating and a price target of $11.88.
TipRanks · 03/08 14:01
Analysts Offer Insights on Healthcare Companies: Joint (JYNT), Xtant Medical Holdings (XTNT) and Oncternal Therapeutics (ONCT)
Joint (JYNT) and Xtant Medical Holdings (XTNT) have received a lot of coverage today. Craig-Hallum analyst Jeremy Hamblin reiterated a Hold rating on Joint today. Oncternal Therapeutics (ONCT) has been upgraded to Buy.
TipRanks · 03/08 13:50
JYNT Stock Earnings: Joint Misses EPS, Beats Revenue for Q4 2023
Joint reported earnings per share of -75 cents. The company reported revenue of $30.61 million. This was 5.28% better than the analyst estimate of $29.08 million for joint's quarterly results. The stock is down 2.7% today.
Investorplace · 03/08 03:52
Joint Corp reports results for the quarter ended in December - Earnings Summary
Joint Corp reports results for the quarter ended in December. The company reported a quarterly adjusted loss of 75 cents per share. Revenue rose 10.1% to $30.61 million from a year ago. Joint Corp shares had fallen by 1.7% this quarter.
Reuters · 03/08 01:03
The Joint Corp. (JYNT) Q4 Earnings and Revenues Top Estimates
NASDAQ · 03/07 23:55
The Joint Corp. Sees FY24 System-Wide Sales $530M-$545M; System-Wide Comp Sales For All Clinics Open 13 Months Or More 4%- Mid-Single Digits; New Franchised Clinic Openings Excluding The Impact Of Refranchised Clinics 60-75
Benzinga · 03/07 22:15
Joint Corp Earnings Presentation Released Online
TipRanks · 03/07 22:02
*Joint: 2024 System-Wide Sales Are Expected Between $530M and $545M Compared to $488.0M in 2023 >JYNT
Dow Jones · 03/07 21:25
More
Webull provides a variety of real-time JYNT stock news. You can receive the latest news about Joint Corp through multiple platforms. This information may help you make smarter investment decisions.
About JYNT
The Joint Corp. is an operator, manager and franchisor of chiropractic clinics that uses a private pay, non-insurance, cash-based model. The Company operates through two segments: Corporate Clinics and Franchise Operations. The Corporate Clinics segment is comprised of the operating activities of the Company-owned or managed clinics. The Company operates or manages approximately 135 clinics under this segment. The Franchise Operations segment is comprised of the operating activities of the franchise business unit. The franchise system consists of approximately 800 clinics in operation. It offers a range of membership and wellness packages. It offers its patients the opportunity to visit its clinics without an appointment and receive prompt attention. Each patient's records are digitally updated for ready retrieval in its data storage system by its chiropractors in compliance with various applicable medical records security and privacy regulations.